Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001784606-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-02 | 2026-02-26+ | JAZZ | Carr Patricia | SVP, CAO | S - Sale | $192.60 | -2,370 | 9,235 | -20% | -$456.5K |
| 2026-03-02 | 2026-02-26 | JAZZ | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,223 | 11.6K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-26 | S | D | 1,253 | $194.11 | 10,352 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $193.7300 to $194.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2026-02-26 | A | A | 2,223 | $0.00 | 11,605 | D | — | — | |
| 3 | Common | Ordinary Shares | 2026-02-27 | S | D | 1,117 | $190.91 | 9,235 | D | — | — |